微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -8.43% | -30.7% | -112.88% | 128/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -3.96% | -277.14% | 77.79% | 126/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -17.83% | -31.1% | -96.8% | 125/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -9.06% | -43.81% | -40.47% | 128/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -6.45% | 3.15% | -514.29% | 129/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -1.05% | -29.63% | 92.28% | 119/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -13.6% | 19.57% | -115.87% | 126/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | -6.3% | -12.1% | 5.41% | 125/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -6.66% | -3.58% | -722.22% | 128/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -0.81% | -209.46% | 95.21% | 116/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -16.91% | -30.08% | -200.89% | 126/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | -5.62% | 34.04% | 12.6% | 121/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | -6.43% | -8.25% | -968.92% | 125/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.74% | 125.52% | 105.69% | 95/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | -13% | -26.09% | -52.58% | 125/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | -8.52% | -29.68% | -43.43% | 116/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | -5.94% | -21.72% | -104.83% | 122/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | -2.9% | -16.94% | 71.87% | 109/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | -10.31% | 0.77% | -56.93% | 125/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | -6.57% | -1.23% | -34.63% | 105/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | -4.88% | 46.55% | -96.77% | 116/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | -2.48% | 27.27% | 76.13% | 94/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | -10.39% | -77% | -60.09% | 125/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | -6.49% | 2% | 28.92% | 87/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | -9.13% | 0.98% | -167.74% | 110/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | -3.41% | 2% | 41.91% | 76/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | -5.87% | 51.45% | 36.33% | 114/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-06-30 | -9.22% | 61.24% | 23.74% | 74/141 | 6.76% | 祥生医疗 | 28.56% | 行业排名> |
| 2018-12-31 | -12.09% | -10.61% | 49.18% | 108/141 | 14.23% | 心脉医疗 | 31.04% | 行业排名> |
| 2018-06-30 | -23.79% | -1662.22% | -117.66% | 61/141 | 4.54% | 新华医疗 | 13.55% | 行业排名> |
| 2017-12-31 | -10.93% | 56.49% | -709.63% | 101/141 | 14.51% | 安旭生物 | 48.71% | 行业排名> |
| 2017-06-30 | -1.35% | 85.53% | 94.63% | 55/141 | 6.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2016-12-31 | -25.12% | -30.83% | -169.24% | 79/141 | 16.44% | *ST明德 | 14.54% | 行业排名> |
| 2016-06-30 | -9.33% | 2% | 51.41% | 50/141 | 6.35% | 迈瑞医疗 | 11% | 行业排名> |